Stock market crash: A FTSE 100 stock I’d buy as a global recession looms

Looking for stocks to protect you from the upcoming global recession? Royston Wild picks out one FTSE 100 hero he thinks you should consider right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s clear by now we’re in the throes of a severe global recession. Lockdown measures continue to be rolled back, but the financial implications of the Covid-19 breakout will be harder to shake off.

Stock pickers need to be more careful in this tough macroeconomic and geopolitical environment. Current events don’t mean they need to run for the hills though. There remain plenty of FTSE 100 shares that should remain profit-making, even as a sharp downturn develops.

A perfect stock for a global recession

Unilever (LSE: ULVR) is a blue-chip I own. I bought it because its products remain in high demand even when broader consumer confidence sinks. Its products are expensive, relatively speaking. But they aren’t so dear that shoppers begin to shun them as their wallets become lighter.

The FTSE 100 comany’s beauty labels, household goods, and food ranges are popular for a number of reasons. It’s a result of the huge sums it pays to market them and keep them living in the public’s consciousness. It’s also because Unilever is committed to innovation to keep its brands fresh, talked about, and reflecting changes in broader consumer behaviour.

Sales of its Dove products, for example, have benefitted recently due to what it calls “microbiome-friendly innovations.” In layman’s terms, this refers to producing products that are kinder to the billions of natural microorganisms that live on the surface of the skin. Many see microbiome-friendly formulations as the future of skincare.

Beloved brands

You don’t have to take my word on just how popular Unilever’s goods are all over the planet. Kantar Worldpanel’s Brand Footprint 2020 report perfectly illustrates the love affair global consumers have with its brands.

Of the world’s top 10 most chosen brands, the FTSE 100 firm can lay claim to three of them. Lifebuoy is the globe’s best-selling soap and sits in fifth place on the list. Sunsilk is perched in seventh position as the most popular haircare product. And its Dove stable of beauty products sits one place lower in eighth.

This sort of popularity means Unilever can lift prices on its products without suffering a meaningful dent in volumes too. It’s a quality that exists in both good and bad times.

Too cheap!

Current City forecasts reflect the resilience of Unilever’s operations. Sure, the number-crunchers expect annual earnings to dip 2% in 2020. This is a reflection of the temporary impact that lockdown measures have had on consumer demand in the early part of the year. Indeed, the FTSE 100 share’s profits are predicted to rise 7% in 2021 on the back of its recession-proof suite of products.

Today, Unilever trades on a forward price-to-earnings (P/E) ratio of 18.5 times. Okay, it’s a little above the Footsie historical average. But it still reflects great value given its position as the ultimate ‘peace of mind’ stock. I’m thinking of buying more shares in the consumer goods goliath. Especially with a global recession almost upon  us.

Royston Wild owns shares of Unilever. The Motley Fool UK owns shares of and has recommended Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »